| Literature DB >> 27446657 |
Jenny T Mac1, Vicente Nuñez2, Joshua M Burns2, Yadir A Guerrero2, Valentine I Vullev3, Bahman Anvari3.
Abstract
Constructs derived from mammalian cells are emerging as a new generation of nano-scale platforms for clinical imaging applications. Herein, we report successful engineering of hybrid nano-structures composed of erythrocyte-derived membranes doped with FDA-approved near infrared (NIR) chromophore, indocyanine green (ICG), and surface-functionalized with antibodies to achieve molecular targeting. We demonstrate that these constructs can be used for targeted imaging of cancer cells in vitro. These erythrocyte-derived optical nano-probes may provide a potential platform for clinical translation, and enable molecular imaging of cancer biomarkers.Entities:
Keywords: (110.3080) Infrared imaging; (160.1435) Biomaterials; (160.4236) Nanomaterials; (170.2520) Fluorescence microscopy; (170.3880) Medical and biological imaging
Year: 2016 PMID: 27446657 PMCID: PMC4929643 DOI: 10.1364/BOE.7.001311
Source DB: PubMed Journal: Biomed Opt Express ISSN: 2156-7085 Impact factor: 3.732